Recce Pharmaceuticals (PK) Quote - RECEF

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

Current Price

0.60

Bid

0.60

Offer

0.60

Volume

0.00 Day's Range 0.00

0.55 52 Week Range 0.60

Market Cap

122.371M

Previous Close

0.60

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

203,951,863

Dividend Yield

PE Ratio

-5.43

Earnings Per Share (EPS)

-0.09

Revenue

5.03M

Net Profit

-17.66M

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.recce.com.au

Headquarters

Perth, Western Australia, Aus

Founded

Recce Pharmaceuticals (PK) is listed in the Pharmaceutical Preparations sector of the OTCMarkets with ticker RECEF. The last closing price for Recce Pharmaceuticals (PK) was US$0.60. Over the last year, Recce Pharmaceuticals (PK) shares have traded in a share price range of US$ 0.55 to US$ 0.60.

Recce Pharmaceuticals (PK) currently has 203,951,863 shares in issue. The market capitalisation of Recce Pharmaceuticals (PK) is US$122.37 million. Recce Pharmaceuticals (PK) has a price to earnings ratio (PE ratio) of -5.43.

No news to show yet.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0.6	0.6	0.6	0	0	CS
52	0.05	9.09090909091	0.55	0.6	0.55	286	0.575	CS
156	0	0	0.6	0.6	0.461	802	0.51183102	CS
260	0.1201	25.0260470931	0.4799	0.9998	0.461	2268	0.82779647	CS

RECEF - Frequently Asked Questions (FAQ)

What is the current Recce Pharmaceuticals (PK) share price?

The current share price of Recce Pharmaceuticals (PK) is US$ 0.60

How many Recce Pharmaceuticals (PK) shares are in issue?

Recce Pharmaceuticals (PK) has 203,951,863 shares in issue

What is the market cap of Recce Pharmaceuticals (PK)?

The market capitalisation of Recce Pharmaceuticals (PK) is USD 122.37M

What is the 1 year trading range for Recce Pharmaceuticals (PK) share price?

Recce Pharmaceuticals (PK) has traded in the range of US$ 0.55 to US$ 0.60 during the past year

What is the PE ratio of Recce Pharmaceuticals (PK)?

The price to earnings ratio of Recce Pharmaceuticals (PK) is -5.43

What is the cash to sales ratio of Recce Pharmaceuticals (PK)?

The cash to sales ratio of Recce Pharmaceuticals (PK) is 19.03

What is the reporting currency for Recce Pharmaceuticals (PK)?

Recce Pharmaceuticals (PK) reports financial results in AUD

What is the latest annual turnover for Recce Pharmaceuticals (PK)?

The latest annual turnover of Recce Pharmaceuticals (PK) is AUD 5.03M

What is the latest annual profit for Recce Pharmaceuticals (PK)?

The latest annual profit of Recce Pharmaceuticals (PK) is AUD -17.66M

What is the registered address of Recce Pharmaceuticals (PK)?

The registered address for Recce Pharmaceuticals (PK) is SUITE 10, 3 BRODIE HALL DRIVE, BENTLEY, PERTH, WESTERN AUSTRALIA, 2000

What is the Recce Pharmaceuticals (PK) website address?

The website address for Recce Pharmaceuticals (PK) is www.recce.com.au

Which industry sector does Recce Pharmaceuticals (PK) operate in?

Recce Pharmaceuticals (PK) operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
EGIOQEdgio Inc (CE)	US$ 0.01 (999,900.00%)	584
AAGRAfrican Agriculture Holdings Inc (CE)	US$ 0.008 (799,900.00%)	477
THCBFTHC Biomed International Limited (CE)	US$ 0.001 (99,900.00%)	100
AEORFAEON REIT Investment Corporation (PK)	US$ 796.08 (26,436.00%)	1
EFTReFFECTOR Therapeutics Inc (CE)	US$ 0.0002 (19,900.00%)	225
UFABQUnique Fabricating Inc (CE)	US$ 0.000001 (-99.98%)	102.53k
VICFFVice Health and Wellness Inc (CE)	US$ 0.000001 (-99.97%)	996
SAFSSafer Shot Inc (CE)	US$ 0.000001 (-99.93%)	2.54M
ERFBERF Wireless Inc (CE)	US$ 0.0001 (-99.89%)	99.77k
ARVLFArrival (CE)	US$ 0.0002 (-99.60%)	42.86k
AITXArtificial Intelligence Technology Solutions Inc (PK)	US$ 0.0038 (52.00%)	608.97M
HMBLHUMBL Inc (PK)	US$ 0.0009 (0.00%)	546.25M
PHILPHI Group Inc (PK)	US$ 0.0003 (0.00%)	501.07M
CBIACanopus Biopharma Inc (PK)	US$ 0.0002 (100.00%)	281.95M
RDARRaadr Inc (PK)	US$ 0.00125 (-10.71%)	169.44M